Browse by ▼

Paul Franke

Editor's Choice

  • The Strongest “Value” Buy in Today’s Stock Market

    By Paul Franke - November 29, 2012 | Tickers: DELL, HPQ | Editor's Choice

    Hewlett-Packard (NYSE: HPQ) is by far the most interesting and misunderstood “value” play in the stock market during late 2012.

  • Crude Oil is Going to $500 a Barrel (Part 1)

    By Paul Franke - March 12, 2012 | Tickers: BP, CVX, COP, XOM, RDS-A | Editor's Choice

    Quantemonics Investing (QI) is projecting US$500 a barrel for crude oil in 8 years, basically compounding at the same rate as it has since 1999, between 2012 and 2020.  While mainstream prognosticators are confidently predicting oil will decline soon with today’s “Don’t Worry Be Happy” market sentiment backdrop, the truly contrarian stance may be to prepare for starkly higher oil and energy pricing.

  • Medtronic – Market Volatility Medicine for your Portfolio

    By Paul Franke - February 22, 2012 | Tickers: ABT, BDX, BCR, JNJ, MDT, STJ | Editor's Choice

    Medtronic (NYSE: MDT) hits the mark for Quantemonics Investing (QI) as a terrific low beta, blue-chip investment idea that is both undervalued and defensive.  Using the Quanteminics C.R.E.D.S. formula, MDT has been an exceptional value for new investors, trading under $40 per share in 2011 and early 2012.